SOPHiA GENETICS (SOPH) Consolidated Net Income (2020 - 2026)

SOPHiA GENETICS has reported Consolidated Net Income for 6 years, with the latest figure at -$20.0 million in Q4 2025.

• Quarterly Consolidated Net Income fell 43.39% year-over-year to -$20.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$76.0 million (down 26.53% YoY) and the FY2025 annual result came in at -$76.0 million, down 26.53% from the prior year.
• Consolidated Net Income fell to -$20.0 million in Q4 2025 per SOPH's latest filing, from -$18.7 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at -$12.5 million in Q1 2021 and troughed at -$498.3 million in Q3 2021.
• A 5-year average of -$44.6 million and a median of -$19.7 million in 2023 frame the typical range for Consolidated Net Income.
• The sharpest annual moves came in 2021 and 2022: Consolidated Net Income soared 99.26% in 2021, then plunged 102.15% in 2022.
• Over 5 years, Consolidated Net Income stood at -$21.9 million in 2021, then jumped by 33.86% to -$14.5 million in 2022, then plunged by 66.1% to -$24.1 million in 2023, then soared by 42.12% to -$13.9 million in 2024, then plunged by 43.39% to -$20.0 million in 2025.
• According to Business Quant data, Consolidated Net Income over the past three periods registered -$20.0 million, -$18.7 million, and -$20.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.